Skip to content

Clinical trials

Hepatitis C, Chronic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20073
20082
20091
20101
20118
20123
20132
20141
20151
20162
20173
20181
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated3
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Hoffmann-La Roche3
Atea Pharmaceuticals, Inc.2
Debiopharm International SA2
GlaxoSmithKline2
Seoul National University Boramae Hospital2
Asan Medical Center1
Boehringer Ingelheim1
GeneOne Life Science, Inc.1
Hanyang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic31
Hepatitis C13
Acquired Immunodeficiency Syndrome2
Coinfection2
Fibrosis2
Liver Cirrhosis2
Hepatitis1
Hepatitis, Alcoholic1
Hepatitis, Chronic1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.